Leads Biolabs to Speak at YAFO ACCESS ASIA BD Forum @ JPM 2026 维立志博将受邀在雅法 ACCESS ASIA 药通亚洲 BD 论坛 @ JPM 2026 上发表演讲

2026 年 1 月 11 日（旧金山洲际酒店）—我们很高兴地宣布，维立志博创始人、董事长兼CEO 康小强先生将在 ACCESS ASIA 药通亚洲 BD 论坛 @ JPM 2026 上发表演讲。

January 11, 2026 (InterContinental San Francisco) — We’re pleased to announce that Xiaoqiang Kang, Founder, Chairman, and CEO at Leads Biolabs, will speak at the ACCESS ASIA BD Forum @ JPM 2026.

由雅法主办的”ACCESS ASIA”论坛，延续ACCESS CHINA的成功经验，将亚洲领先的生物科技跨境平台拓展至更广阔领域，连接创新者与全球药企、投资机构和战略合作伙伴。论坛将于2026年1月11日在旧金山洲际酒店举行，为亚洲生物科技企业提供全球舞台，展示创新成果，促成战略合作，开拓商业发展新机遇。更多信息请访问：https://biotochina.org/

ACCESS ASIA, hosted by YAFO, builds on the success of ACCESS CHINA, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and strategic partners. Taking place on January 11, 2026, at the InterContinental San Francisco, the forum provides a global stage for Asian biotech companies to showcase their innovation, foster partnerships, and explore new business development opportunities. View more information at: https://biotochina.org/

演讲嘉宾

About the speaker

美国国家癌症研究所（NCI）博士后研究员，在外科主任Steven Rosenberg实验室从事肿瘤免疫疗法研究。

超过30年创新药研发经验，其中17年以上抗体新药研发经验，领导多个抗癌抗体新药研发。

曾任美国礼来制药首席科学家兼资深课题组长，参加Erbitux研发和成功上市。

同济医学院血液学硕士，美国北德克萨斯大学生物医学博士。

Postdoc in tumor immunotherapy at Surgery Branch Chief Dr. Steven Rosenberg’s lab in NCI/NIH

Over 30 years of experience in the R&D of innovative drugs, particularly in antibody drugs

Previously served as Principal Scientist and Senior Group Leader at Eli Lilly Pharmaceuticals, and contributed to the development and successful launch of Erbitux®

MS in Hematology from Tongji Medical School, PhD in Biologic Medicine from North Texas University

关于ACCESS ASIA药通亚洲 BD Forum @ JPM 2026

About ACCESS ASIA BD Forum @ JPM 2026

2026 年 1 月 11 日， ACCESS ASIA 药通亚洲BD论坛 @ JPM 2026 将在美国旧金山洲际酒店正式举行。

ACCESS ASIA BD Forum @ JPM is scheduled to be held on January 11, 2026, at the InterContinental San Francisco, alongside the J.P. Morgan Healthcare Conference Week.

本次为期一天的论坛将呈现主题演讲、圆桌讨论、企业路演、公司展示，以及 1 对 1 合作洽谈，旨在连接亚洲领先的生物科技创新者与全球制药公司、投资机构及战略合作伙伴。

This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners.

会议名称: ACCESS ASIA 药通亚洲BD论坛 @ JPM 2026
时间 & 地点: 2026 年 1 月 11 日 | 旧金山洲际酒店
更多活动详情请至: https://biotochina.org/

Conference Name: ACCESS ASIA BD Forum @ JPM 2026
Date & Venue: January 11, 2026 | InterContinental San Francisco
View more information at: https://biotochina.org/